- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT03985111
Does a Central Venous Line Reduce Perioperative Fluid Administration?
In High Risk Patients Undergoing Elective Colorectal Resection, Does Routine Placement of a Central Venous Catheter Reduce Peri-operative Fluid Administration in Theatre and the Critical Care Unit?
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
There are several indications for elective central venous cannulation in major colorectal surgery, particularly in those at a higher risk of morbidity and mortality. These include: the ability to infuse certain vasoactive medications, monitor central venous pressure, allow for frequent blood sampling, and provide a route of access for total parenteral nutrition(1). Furthermore, there has been a great deal of recent interest in whether there are improved outcomes with restrictive as opposed to liberal fluid therapy in major abdominal surgery(2), and, similarly, with individualised, rather than generic, blood pressure management in major surgery(3). However, there have been no major studies to date examining whether the simple act of electively inserting a central venous catheter prior to the start of surgery influences the volume of fluid infused and the use of vasopressors perioperatively.
The RELIEF trial reported that modestly liberal perioperative fluid regimens conferred no greater disability-free survival benefit over restrictive regimens, but are likely to reduce rates of acute kidney injury(2). This contrasts with the restrictive protocols championed by various Enhanced Recovery After Surgery (ERAS) programs(4). Previous works have suggested that not only does adherence to ERAS principles lead to superior patient outcomes, but some have gone further in identifying restriction of intravenous fluids perioperatively to be one of the few interventions that independently predicts a better outcome(5). One of the advantages of central venous catheterisation is the ability to administer drugs in smaller volumes of fluid. Therefore, given the intensity of the debate surrounding restrictive and liberal regimens, it should be investigated whether the availability of central venous access impacts upon the volumes of fluid infused.
Furthermore, central venous catheterisation is unlikely just to have an impact via the avoidance of inadvertent larger volume infusion, which is sometimes seen with drug administration through a peripheral line. The RELIEF trial reported that the patient cohort managed with a restrictive fluid regimen were more likely to receive vasopressor support, compared with those receiving a liberal regimen(2). The presence of a central venous catheter enables the use of potent vasopressor agents, such as noradrenaline, which will further influence fluid administration, by introducing a second therapeutic option for correcting perioperative hypotension. The importance of 'tight' blood pressure control has been demonstrated by the INPRESS trial, which showed a reduction in post-operative organ dysfunction with individualised blood pressure management, over standard management strategies(3). This is of particular importance, as evidence has shown that cardiac output-directed fluid therapy should not lead to 'excessive fluid administration, but may lead to a more individualised approach to achieving the correct dose of fluid'(6), and may require concomitant use of vasoactive agents.
Thus, the investigators have set out to investigate whether the elective insertion of a central venous catheter prior to the start of major colorectal surgery, influences the volumes, and types, of fluid infused, as well as the use and mean dose of vasopressor agents, intra-operatively and for the first 12 hours post-operatively.
- Smith, RN, et al., 'Central venous catheters', BMJ 2013; 347:f6570
- Myles, PS, et al., 'Restrictive versus Liberal Fluid Therapy for Major Abdominal Surgery', N Engl J Med 2018; 378:24
- Futier, E, et al., 'Effect of Individualised vs Standard Blood Pressure Management Strategies on Postoperative Organ Dysfunction Among High-Risk Patients Undergoing Major Surgery', JAMA 2017; 318(14):1346
- Feldheiser, A, et al., 'Enhanced Recovery After Surgery (ERAS) for gastrointestinal surgery, part 2: consensus statement for anaesthesia practice', Acta Anaesthesiologica Scandinavia 2016, 60:289
- Gustafsson, UO, et al., 'Adherence to the Enhanced Recovery After Surgery Protocol and Outcomes After Colorectal Cancer Surgery', Arch Surg 2011; 146(5):571
- Pearse, RM, et al., 'Effect of a Perioperative Cardiac Output- Guided Haemodynamic Therapy Algorithm on Outcomes Following Major Gastrointestinal Surgery', JAMA 2014; 311(21):2181
Tipo de estudio
Inscripción (Actual)
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
-
London, Reino Unido, E11 1NR
- Whipps Cross Hospital, Barts Health NHS Trust
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Método de muestreo
Población de estudio
Descripción
Inclusion Criteria:
The inclusion criteria will be all adult patients presenting for elective major colorectal surgery (resection), whom are to be electively admitted to critical care directly from theatre.
Exclusion Criteria:
- Patients under 18 years of age
- Patients undergoing emergency surgery
- Those not admitted electively to critical care directly from theatre
- Those patients that do not undergo any bowel resection
- Patients in whom central venous catheter insertion is as an emergency peri- operatively
- Patients refusing/unable to give valid informed consent
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
Cohortes e Intervenciones
Grupo / Cohorte |
Intervención / Tratamiento |
|---|---|
|
No CVC inserted
Patients undergoing major elective colorectal resection without central venous catheter inserted pre-operatively
|
|
|
CVC inserted
Patients undergoing major elective colorectal resection with a central venous catheter inserted pre-operatively
|
Insertion of a central venous catheter insertion pre-operatively (electively)
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Volume of intravenous fluid infused intra-operatively
Periodo de tiempo: Intra-operatively (from induction to leaving theatre)
|
To assess whether the presence of a central venous catheter influences the volume of intravenous fluid infused intra-operatively
|
Intra-operatively (from induction to leaving theatre)
|
|
Volume of intravenous fluid infused post-operatively
Periodo de tiempo: The first 12 hours post-operatively (commencing from the arrival on the critical care unit, until the end of the 12th post-operative hour)
|
To assess whether the presence of a central venous catheter influences the volume of intravenous fluid infused post-operatively
|
The first 12 hours post-operatively (commencing from the arrival on the critical care unit, until the end of the 12th post-operative hour)
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Length of Intensive Care Unit Stay
Periodo de tiempo: From admission to intensive care, until stepdown to the ward (and until the expected end of study on 30th April 2020)
|
Does the presence of a central venous catheter alter length of post-operative stay on the Intensive Care Unit
|
From admission to intensive care, until stepdown to the ward (and until the expected end of study on 30th April 2020)
|
|
Volume of blood product infused peri-operatively
Periodo de tiempo: From induction of anaesthesia until the end of the 12th post-operative hour
|
To assess whether the presence of a central venous catheter influences the volume of blood products infused peri-operatively
|
From induction of anaesthesia until the end of the 12th post-operative hour
|
|
Mean dose of required vasopressor agents
Periodo de tiempo: From induction of anaesthesia until the end of the 12th post-operative hour
|
To assess whether the presence of a central venous catheter influences the mean dose of any required vasopressor agents peri-operatively
|
From induction of anaesthesia until the end of the 12th post-operative hour
|
|
Use of cardiac output (flow-monitoring) equipment
Periodo de tiempo: From induction of anaesthesia until the end of the 12th post-operative hour
|
To assess whether the presence of a central venous catheter, and any ensuing fluid and blood pressure management strategies, influence the use of cardiac output monitoring equipment peri-operatively
|
From induction of anaesthesia until the end of the 12th post-operative hour
|
|
Length of hospital stay
Periodo de tiempo: From the day of the procedure until discharge from the hospital (and until the expected end of study on 30th April 2020)
|
To assess whether the presence of a central venous catheter influences the total post-operative length of stay
|
From the day of the procedure until discharge from the hospital (and until the expected end of study on 30th April 2020)
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Director de estudio: David Melia, MBBS, Barts & The London NHS Trust
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- 012593
- 19/LO/0099 (Otro identificador: HREC)
- 252375 (Otro identificador: IRAS)
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .